Factors influencing consumer use of written drug information

Annals of Pharmacotherapy

Volumn 37, Issue 2, 2003, Pages 259-267

  Koo, Michelle M ^a   Krass, Ines ^b   Aslani, Parisa ^b   Guzmàn, Wilma M ^b   Le Duff, Michel ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

Consumers; Written drug information

Indexed keywords

ANXIETY; ARTICLE; CONSUMER; DRUG INFORMATION; DRUG USE; ENVIRONMENTAL FACTOR; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL;

EID: 0037317139     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700218     Document Type: Article

References (96)

1. Buck ML. Providing patients with written medication information. Ann Pharmacother 1998;32:962-9.
2. Johnson MW, Mitch WE, Sherwood J, Lopes L, Schmidt A, Hartley H. The impact of a drug information sheet on the understanding and attitude of patients about drugs. JAMA 1986;256:2722-4.
3. Steering Committee. Action plan for the provision of useful prescription medicine information. Dec 1996. Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information [cited 2002 June 14]. Available from: URL: http://www.keystone.org/final/appen.html.
4. Nightingale SL. Written patient information on prescription drugs, Int J Technol Assess Health Care 1995;11:399-409.
5. Raynor DK. Patient compliance: the pharmacist's role. Int J Pharm Pract 1992;1:126-35.
6. Whittet TD. The viewpoint of the European experience. Drug Inf J 1977;11(suppl):26S-34S.
7. White S. Patient information in Europe. SCRIP 1988;(Oct)1350:8-9.
8. Wilkes D. Providing patients with better information. SCRIP 1992 (June):35-6.
9. Council Directive. Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets. Chapter III - User Package Leaflet; April 30, 1992. Official J Eur Commun 1992;113(Apr):8-12.
10. Vander Stichele RH, Bogaert. MG. European legislation and research projects regarding patient education for medication. Drug Inf J 1995;29:285-90.
11. Blattmann P. Patient product information (PPI) - elements for a rational approach. Drug Inf J 1992;26:271-8.
12. Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns 2001;43:147-9.
13. Baume P. A question of balance: report on the future of drug evaluation in Australia - commissioned for the Minister for Aged, Family and Health Services, the Hon. Peter Staples. Canberra: Australian Government Publishing Service, July 1991.
14. Shenfield GM. Tasker JL. History in the making: the evolution of consumer product information (CPI). Med J Aust 1997;166:425-8.
15. Baker P, Consumer product information. Pharmacy News 1994;(January):11.
16. Livingstone CR, Pugh ALG, Winn S, Williamson VK. Developing community pharmacy services wanted by local people: information and advice about prescription medicines. Int J Pharm Pract 1996;4:94-102.
17. Wilson M, Robinson E, Blenkinsopp A, Panton R. Customers' recall of information given in community pharmacies. Int J Pharm Pract 1992;1:152-9.
18. Ascione FJ, Shimp LA. The effectiveness of four education strategies in the elderly. Drug Intell Clin Pharm 1984;18:926-31.
19. Morrow N, Hargie O. Woodman C. Consumer perceptions of and attitudes to the advice-giving role of comnmnity pharmacists. Pharm J 1993;251:25-7.
20. Livingstone C, Hayes A, Ladenheim D. Verbal advice about prescription medicines in community pharmacies. Pharm J 1993(suppl);251:R6.
21. ASHP guidelines on pharmacist-conducted patient counseling. Am J Hosp Pharm 1993;50:505-6.
22. Raynor DK, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J 2000;264:268-70.
23. Vander Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. Ann Pharmacother 1991;25:1002-6.
24. Bandesha G, Raynor DK, Teale C. Preliminary investigation of patient information leaflets as package inserts. Int J Pharm Pract 1996;4:246-8.
25. Knapp P, Raynor DK. A telephone survey of patients' use of medicine information leaflet. Presented at: the British Pharmaceutical Conference, Cardiff, September 13-15, 1999. Pharm J 1999(suppl);263:R40.
26. Amery WK, Van Winkel M. Patient package inserts for prescription drugs in an international pharmaceutical company. Drug Inf J 1995;29:51-60.
27. Berry DC, Michas IC, Gillie T, Forster M. What do patients want to know about their medicines, and what do doctors want to tell them? A comparative study. Psychol Health 1997;12:467-80.
28. Graham JD, Kwok YS. What consumers want to know about medicines. Aust Prescriber 1995;18:10-1.
29. Dodds LJ, King RW. Factors affecting attitudes to the provision of information with prescribed drugs. Pharm J 1989;242(suppl):R7-R12.
30. Gibbs S, Waters WE, George CF. The benefits of prescription information leaflets (1). Br J Clin Pharmacol 1989;27:723-39.
31. Peura S, Klaukka T, Hannula AM, Eerikainen S. Electronically produced information leaflets increase patients' understanding of antibiotics. Int J Pharm Pract 1993;2:22-5.
32. Winfield AJ, Owen CW. Information leaflets: a means of improving patient compliance. Brit J Pharm Pract 1990;12:206-9.
33. Arthur VAM. Written patient information: a review of the literature. J Adv Nuts 1995;21:1081-6.
34. Mottram D, Reed C. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public. J Clin Pharm Ther 1997;22:127-34.
35. Van Haecht CHM, Vander Stichele R, De Backer G, Bogaert. MG. Impact of patient package inserts on patients' satisfaction, adverse drug reactions and risk perception: the case of NSAIDs for posttraumatic pain relief. Patient Educ Couns 1991;17:205-15.
36. Gibbs S, Waters WE, George CE The benefits of prescription information leaflets (2). Br J Clin Pharmacol 1989;28:345-51.
37. Koo M, Aslani P. Krass I. Consumer opinions on medicines information and factors affecting its use - an Australian experience. Int J Pharm Pract 2002;10:107-14.
38. Lloyd AK. A CPI dilemma: refused prescriptions. Aust Pharm 1994;13:656.
39. Meade CD, Byrd JC. Patient literacy and the readability of smoking education literature. Am J Public Health 1989;79:204-6.
40. Sarma M, Alpers JH, Prideaux DJ, Kroemer DJ. The comprehensibility of Australian educational literature for patients with asthma. Med J Aust 1995;162:360-3.
41. Beaver K, Luker K. Readability of patient information booklets for women with breast cancer. Patient Educ Courts 1997;31:95-102.
42. Payne S, Large S, Jarrett N, Turner P, Written information given to patients and families by palliative care units: a national survey (letter). Lancet 2000;355:1792.
43. Basara LR, Juergens JP. Patient package insert readability and design. Am Pharm 1994;NS34:48-53.
44. Baker SJ. Who can read consumer product information? Aust J Hosp Pharm 1997;27:126-31.
45. Estrada CA, Martin Hryniewicz M, Barnes Higgs V, Collins C, Byrd JC. Anticoagulant patient information material is written at high readability levels. Stroke 2000;31:2966-70.
46. Rolland PD. Reading level of drug information printouts: a barrier to effective communication of patient medication information. Drug Inf J 2000;34:1329-38.
47. Buchbinder R, Hall S, Grant G, Mylvaganam A, Patrick MR. Readability and content of supplementary written drug information for patients used by Australian rheumatologists. Med J Aust 2001;174:575-8.
48. Kenny T, Wilson RG, Purves IN, Clark J, Newton LD, Newton DP, et al. A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future. Fam Pract 1998;15:471-9.
49. Ley P, Florio T. The use of readability formulas in health care. Psychol Health Med 1996;1:7-28.
50. Ley P. The use and improvement of written communication in mental health care and promotion. Psychol Health Med 1998;3:19-53.
51. Kitching JB. Patient information leaflets - the state of the art. J R Soc Med 1990;83:298-300.
52. Mayberry JF, Mayberry M. Effective instructions for patients. J R Coll Physicians Lond 1996;30:205-8.
53. Krass I, Svarstad BL, Bultman D. Using alternative methodologies for evaluating patient medication leaflets. Patient Educ Couns 2002;47:29-35.
54. Newton L, Newton D, Clark J, Kenny T, Mosely D, Purves I, et al. Patient information leaflets: producing understandable PILs. J Inf Sci 1998;24:167-81.
55. Coulter A. Evidence based patient information. BMJ 1998;317:225-6.
56. Bernardini C, Ambrogi V, Perioli L, Tiralti MC, Fardella G. Comprehensibility of the package leaflets of all medicinal products for human use: a questionnaire survey about the use of symbols and pictograms. Pharmacol Res 2000;41:679-88.
57. Bernardini C, Ambrogi V, Fardella G, Perioli L, Grandolini G. How to improve the readability of the patient package leaflet: a survey of the use of colour, print size and layout. Pharmacol Res 2001;43:437-43.
58. Doak, CC, Doak LG, Root JH. Teaching patients with low literacy skills. 2nd ed. Philadelphia: JB Lippincott, 1996.
59. Kirkpatrick MF, Mohler BS. Using the readability assessment instrument to evaluate patient medication leaflets. Drug Inf J 1999;33:557-63.
60. Sless D, Wiseman R. Writing about medicines for people - usability guidelines for consumer medicine information. 2nd ed. Canberra: Australian Government Publishing Service, 1997.
61. Steering Committee. Action plan for the provision of useful prescription medicine information - Appendix G: specific language and format guidelines, with samples. Dec 1996. Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information [cited 2002 June 14]. Available from: URL: http://www.keystone.org/final/appen.html.
62. Raynor DK. Writing patient information - a pharmacist's guide. Pharm J 1992;249:180-2.
63. Ley P, Morris L. Psychological aspects of written information for patients. In: Rachman S, ed. Contributions to medical psychology. Vancouver: Pergamon Press, 1984.
64. Ley P. Communicating with patients: improving communication, satisfaction and compliance. Cheltenham: Stanley Thornes, 1997.
65. Andrus MR, Roth MT. Health literacy: a review. Pharmacotherapy 2002;22:282-302.
66. Mayeaux EJ, Murphy PW, Arnold C, Davis TC, Jackson RH, Sentell T. Improving patient education for patients with low literacy skills. Am Fam Physician 1996;53:205-11.
67. Giorgianni SJ. Responding to the challenge in health literacy. The Pfizer Journal. New York: Impact Communications [cited 2002 June 26]. Available from: URL: http/www.thepfizerjournal.com/TPJ04.pdf.
68. Williams MV, Parker RM, Baker DW, Parikh NS, Pitkin K, Coates WC, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA 1995;274:1677-82.
69. Davis TC, Michielutte R, Askov EN, Williams MV, Weiss BD. Practical assessment of adult literacy in health care. Health Educ Behav 1998;25:613-24.
70. Parker R, Baker D, Williams M, Nurss J. The Test of Functional Health Literacy in Adults (TOFHLA): a new instrument for measuring patients' literacy skills. J Gen Intern Med 1995:10:537-45.
71. Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to measure functional health literacy. Patient Educ Couns 1999;38:33-42.
72. Taylor W. Cloze procedure: a new tool for measuring readability. Journal Q 1953;30:415-33.
73. Weiss BD, Coyne C, Michielutte R, Davis TC, Meade CD, Doak CC. et al. Communicating with patients who have limited literacy skills: report of the national work group on literacy and health. J Fam Pract 1998;46:168-76.
74. Ad hoc Committee on Health Literacy for the Council on Scientific Affairs AMA. Health literacy: report of the Council on Scientific Affairs. 1999;281:552-7.
75. Parikh NS, Parker RM, Nurss JR, Baker DW, Williams MV. Shame and health literacy: the unspoken connection. Patient Educ Couns 1996;27:33-9.
76. Wellwood I, Dennis MS, Warlow CP. Perceptions and knowledge of stroke among surviving patients with stroke and their carers. Age Ageing 1994;23:293-8.
77. Fortinsky RH, Hathaway TJ. Information and service needs among active and former family caregivers of persons with Alzheimer's disease. Gerontologist 1990;30:604-9.
78. Iconomou G, Vagenakis AG, Kalofonos HP. The informational needs, satisfaction with communication, and psychological status of primary caregivers of cancer patients receiving chemotherapy. Support Care Cancer 2001;9:591-6.
79. Francis S-A, Smith F, Gray N, Graffy J. The roles of informal carers in the management of medication for older care-recipients. Int J Pharm Pract 2002;10:1-9.
80. Gray NJ, Francis S-A, Smith FS. Informal carers and medicines management: information exchange with the pharmacist. Paper presented at the British Pharmaceutical Conference, Birmingham, Sept 10-13, 2000. Pharm J 2000;265:R46.
81. Harvey JL, Plumridge RJ. Comparative attitudes to verbal and written medication information among hospital outpatients. DICP 1991;25:925-8.
82. Conner M, Norman P. The role of social cognition in health behaviours. In: Conner M, Norman P. eds. Predicting health behaviour. Buckingham, England: Open University Press, 1998:1-22.
83. McClelland C, Rees L. A foundation for health promotion in pharmacy practice. In: Gard P, ed. A behavioural approach to pharmacy practice. Oxford: Blackwell Science, 2000:59-90.
84. Shaw C. A framework for the study of coping, illness behaviour and outcomes. J Adv Nurs 1999;29:1246-55.
85. Wallston BS, Wallston KA. Locus of control and health: a review of the literature. Health Educ Monogr 1978;6:107-17.
86. James D, Horne R. The role of patients perception of illness in careseeking behaviour. In: Gard P, ed. A behavioural approach to pharmacy practice. Oxford: Blackwell Science, 2000:91-110.
87. Weinman J. Providing written information for patients: psychological considerations. J R Soc Med 1990;83:303-5.
88. Leydon GM, Boulton M, Moynihan C, Jones A, Mossman J, Boudioni M, et al. Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ 2000;320:909-13.
89. Butow P, Brindle E, McConnell D, Boakes R, Tattersall M. Information booklets about cancer: factors influencing patient satisfaction and utilization. Patient Educ Couns 1998;33:129-41.
90. Miller S, Brody D, Summerton J. Styles of coping with threat: implications for health. J Pers Soc Psychol 1988;54:142-8.
91. Elf M, Wikblad K. Satisfaction with information and quality of life in patients undergoing chemotherapy for cancer. Cancer Nurs 2001;24:351-6.
92. Rosenstock IM. The health belief model: explaining health behavior through expectancies. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass, 1991:39-62.
93. Melnyk KA. Barriers: a critical review of recent literature. Nurs Res 1988;37:196-201.
94. Donovan JL, Blake DR, Fleming WG. The patient is not a blank sheet: lay beliefs and their relevance to patient education. Br J Rheumatol 1989;28:58-61.
95. D'haese S, Vinh-Hung V, Bijdekerke P, Spinnoy M, De Beukeleer M, Lochie N, et al. The effect of timing of the provision of information on anxiety and satisfaction of cancer patients receiving radiotherapy. J Cancer Educ 2000;15:223-7.
96. Stewart D, Erikson B, McHardy K, Cunningham I. Patient information leaflets: a user's perspective. In: 6th Health Services Research and Pharmacy Practice Conferences, Aberdeen - Volume of Abstracts, 2000:2000.19.